Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2026-02-25 @ 5:52 PM
Study NCT ID:
NCT07001969
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-06-03
First Post:
2025-02-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Percutaneous Trans-facet Spine Fixation
Sponsor:
Mahmoud Massoud
Organization:
Study Overview
Official Title:
Massoud-Goel Technique and Theory: Percutaneous Trans-facet Fixation for Treatment of Degenerative Spine
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2025-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Massoud-Goel
Brief Summary:
Percutaneous Trans-facet Fixation Massoud-Goel Technique and Theory for Treatment of Degenerative Spine
Detailed Description:
Massoud-Goel' as rationale treatment for treatment spinal degeneration affected spinal segments using trans-articular screws, without physically distracting the facets, or removal of any part of the bone or ligament.
Following fixing of the segment, all the secondary phenomenon reverse, effectively increasing the canal size and reversing the effects of spinal degeneration and spinal canal stenosis.
Stabilizes the region and provides an environment for resorption of the herniated disc and ultimate arthrodesis of the spinal segments.
Following fixing of the segment, all the secondary phenomenon reverse, effectively increasing the canal size and reversing the effects of spinal degeneration and spinal canal stenosis.
Stabilizes the region and provides an environment for resorption of the herniated disc and ultimate arthrodesis of the spinal segments.
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?: